| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/23/2009 | CN101537050A Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 09/23/2009 | CN101537042A Applied medicament for treating breast neoplasms |
| 09/23/2009 | CN101537038A Pharmaceutical composition for preventing and curing children cold and preparation method thereof |
| 09/23/2009 | CN101537037A Amaranth berberine tablet and preparation method thereof |
| 09/23/2009 | CN101537030A Paste for treating physical trauma |
| 09/23/2009 | CN101537029A Preparation method for extract of cornel containing ursolic acid |
| 09/23/2009 | CN101537023A Medicine for treating cancer |
| 09/23/2009 | CN101537020A Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof |
| 09/23/2009 | CN101537019A Medicine for curing tympanitis |
| 09/23/2009 | CN101537015A Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments |
| 09/23/2009 | CN101537013A Application of nanometer polysaccharide for preparing antineoplastic medicament |
| 09/23/2009 | CN101537012A Complex vitamin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101537011A Pharmaceutical composition for preventing or treating parkinsonism and preparation method thereof |
| 09/23/2009 | CN101537010A Eyedrop preparation and preparation method thereof |
| 09/23/2009 | CN101537009A Production process of compound preparation of ceftriaxone sodium and tazobactam sodium for injection |
| 09/23/2009 | CN101537008A Livestock cefquinome bletilla striata bioadhesive slow-release capsules |
| 09/23/2009 | CN101537007A Application of N-(thiofuran-2) pyrazolo (1, 5-a) pyridine-3-formanides compounds for preparing antineoplastic |
| 09/23/2009 | CN101537006A Application of pyridazinone compounds in preparing antitumor drugs |
| 09/23/2009 | CN101537005A Codein and chlorphenamine compound sustained release capsules |
| 09/23/2009 | CN101537004A Pubes-cleaning disinfection nursing liquid used for pudendum and vagina of human body |
| 09/23/2009 | CN101537003A Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments |
| 09/23/2009 | CN101537002A Diacerein composition with good leaching property, and preparation and use thereof |
| 09/23/2009 | CN101537001A Application of compound as JAK-STAT3 signal passage inhibitor |
| 09/23/2009 | CN101537000A Multi-purpose disinfectant |
| 09/23/2009 | CN101536999A Application of 3,5-dimethoxy-4-hydroxy benzaldehyde in ray protection |
| 09/23/2009 | CN101536998A Composition used for treating AIDS and associated diseases and preparation method thereof |
| 09/23/2009 | CN101536997A Application of ginseng alkynol in pharmacy |
| 09/23/2009 | CN101536995A High imbibition dissoluble drug release external contraceptive membrane |
| 09/23/2009 | CN101536994A Method for preparing hybrid nanofiber membrane capable of loading drug |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536992A Livestock cefquinome colon-targeted pills and preparation method thereof |
| 09/23/2009 | CN101536991A Pentoxyverine voltoide and preparation method thereof |
| 09/23/2009 | CN101536990A Colchicines gastric floating sustained-release tablet and method for preparing same |
| 09/23/2009 | CN101536989A Metformin hydrochloride intragastric floating sustained-release tablet and preparation method thereof |
| 09/23/2009 | CN101536988A Troxerutin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101536987A Sodium alginate microballoon vein suppository containing hemangioma-resisting medicant, preparation method and application thereof |
| 09/23/2009 | CN101536986A Sodium alginate targeted sustained release microsphere vascular occlusive agent containing Sorafenib as well as preparation and application thereof |
| 09/23/2009 | CN101536985A Livestock cefquinome lung-targeted microspheres and preparation method thereof |
| 09/23/2009 | CN101536983A Albendazole oxide hydrochloride premix for animals |
| 09/23/2009 | CN101536981A Clonidine hydrochloride multivesicular liposome and preparation method thereof |
| 09/23/2009 | CN101536980A Rubescensin preparation and preparation method and use of same |
| 09/23/2009 | CN101536979A Edaravone lipid microsphere formulation and preparation method |
| 09/23/2009 | CN101536978A Carboxymethyl starch sodium oral solution and preparation method thereof |
| 09/23/2009 | CN101536977A Gel taking 3 beta, 12, 13- trihydroxy- oleanane-28-acid as active ingredient |
| 09/23/2009 | CN101536975A Gel taking 1, 28- dihydroxy- oleanane-2, 12- diene as active ingredient |
| 09/23/2009 | CN101536974A Eye methazolamide temperature-sensitive situ-gel preparation and preparation method thereof |
| 09/23/2009 | CN101536857A Healthcare pillow for treating periarthritis humeroscapularis and cervical spondylosis |
| 09/23/2009 | CN100543143C Process for enhanced production of pantothenate |
| 09/23/2009 | CN100543140C Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/23/2009 | CN100543137C Novel forms of interfering RNA molecules |
| 09/23/2009 | CN100543022C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542609C Compositions comprising dietary fat complex and methods for their use |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/23/2009 | CN100542542C Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| 09/23/2009 | CN100542540C Nose cavity administering formulation of gastrodine |
| 09/23/2009 | CN100542539C Pharmaceutical compositions for acute glucocorticoid therapy |
| 09/23/2009 | CN100542538C Matrix film tablet with controlled release a natural mixture of conjugated estrogens |
| 09/23/2009 | CN100542537C Oral preparation of prostaglandin E1 |
| 09/23/2009 | CN100542536C Nasal powder of prostaglandin E |
| 09/23/2009 | CN100542535C Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 09/23/2009 | CN100542534C Substituted piperazines |
| 09/23/2009 | CN100542533C Adhesive preparation containing fentanyl |
| 09/23/2009 | CN100542532C Usage of pirfenidone for treating hepatic injury and necrosis and acute lung injury |
| 09/23/2009 | CN100542531C Injection used for improving immunity of human |
| 09/23/2009 | CN100542530C 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/23/2009 | CN100542529C Water soluble silymarin composition and its preparation method |
| 09/23/2009 | CN100542528C Bicyclol micronization and oral release controlling preparation |
| 09/23/2009 | CN100542527C Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
| 09/23/2009 | CN100542526C Medicinal chewing tablet used for antipyretic analgesic and its preparation method |
| 09/23/2009 | CN100542525C Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 09/23/2009 | CN100542524C Pharmaceutical composition containing rasagiline |
| 09/23/2009 | CN100542429C Compositions comprising protein and fatty acid and processes of their preparation |
| 09/22/2009 | US7592478 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592468 pH controlled aqueous solvent extraction from plant material of carboxylic acid form; salt formation and extraction into organic solvent; decarboxylation; filtration and/or chromatographic purification |
| 09/22/2009 | US7592467 Inhibitors of prolyl endopeptidase |
| 09/22/2009 | US7592461 Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 09/22/2009 | US7592458 2-{[2-(N-phenyl-N-(1,2,3,4-tetrahydronaphth-2-yl)amino]ethyl}piperidine; potent membrane stabilizing agents with prolonged effect as infiltration anesthesia, nerve blocks, topical anesthesia, dermal anesthesia. anesthetics; penetration; eyes; mucous membranes; rectal tissues; short onset time |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592454 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists |
| 09/22/2009 | US7592453 Fused quinoline derivative and use thereof |
| 09/22/2009 | US7592451 Glyceraldehyde 3-phosphate dehydrogenase (GADPH) inhibitors and screening compounds |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 09/22/2009 | US7592445 method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount |
| 09/22/2009 | US7592444 siRNA targeting myeloid cell leukemia sequence 1 |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592373 Metabolism diosrders; eating disorders; obesity; antidiabetic agents; incontinence; melanin concentrating hormone; 3-[4-(4-methylpiperidin-1-ylmethyl)phenyl]propynoic acid-(4'-chloro-2'-fluorobiphenyl-4-yl)amide, for example |
| 09/22/2009 | US7592372 Mixture of fudostein, acid and sweetening |
| 09/22/2009 | US7592371 External preparation |
| 09/22/2009 | US7592370 Fatty acid treatment for cardiac patients |
| 09/22/2009 | US7592369 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 09/22/2009 | US7592368 HIV aspartyl protease inhibitors; solubility, bioavailability; viral and HIV infections |
| 09/22/2009 | US7592367 Compounds from Garcinia hanburyi, their use in treating cancer and method of separating epimers thereof |
| 09/22/2009 | US7592366 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted cyclopentane compounds; Isopropyl 5-(3-((1R,2R,3R,5R)-5-chloro-2-(3-chloro-5-(hydroxymethyl)phenethyl)-3-hydroxycyclopentyl)propyl)thiophene-2-carboxylate for example |